When it comes to big data, no other industry has as much at stake as the biopharmaceutical sector. Data from sources like health records, imaging, genome sequencing and wearables are potentially very valuable, and could drive massive improvements in European health systems. Making this data FAIR (findable, accessible, interoperable and reusable) is a simple message with wide appeal to researchers who spend an inordinate amount of time finding, processing, organising and curating data.
Read more
When data is FAIR, citizens ultimately reap the benefit
From a few clicks to a few months - FAIRified datasets can fast-track drug development